ahlam1399
03-22-2016, 06:22 AM
Drugmaker Valeant CEO leaving as investor Ackman joins board
(Reuters) - Drugmaker Valeant Pharmaceuticals International Inc said on Monday its chief executive ******r is leaving and billionaire investor William Ackman would join the board as it tries to clean up accounting problems and save its business. The Canadian company, whose operations include prescription *****, consumer products, and Bausch & Lomb eye care, has lost nearly 90 percent of its value as it came under public scrutiny for its pricing and distribution pra
http://rc.feedsportal.com/r/247395401046/u/49/f/654199/c/35217/s/4e68bc3a/sc/19/rc/1/rc.img (http://rc.feedsportal.com/r/247395401046/u/49/f/654199/c/35217/s/4e68bc3a/sc/19/rc/1/rc.htm)
http://rc.feedsportal.com/r/247395401046/u/49/f/654199/c/35217/s/4e68bc3a/sc/19/rc/2/rc.img (http://rc.feedsportal.com/r/247395401046/u/49/f/654199/c/35217/s/4e68bc3a/sc/19/rc/2/rc.htm)
http://rc.feedsportal.com/r/247395401046/u/49/f/654199/c/35217/s/4e68bc3a/sc/19/rc/3/rc.img (http://rc.feedsportal.com/r/247395401046/u/49/f/654199/c/35217/s/4e68bc3a/sc/19/rc/3/rc.htm)
http://da.feedsportal.com/r/247395401046/u/49/f/654199/c/35217/s/4e68bc3a/sc/19/a2.img (http://da.feedsportal.com/r/247395401046/u/49/f/654199/c/35217/s/4e68bc3a/sc/19/a2.htm)
http://adchoice.feedsportal.com/r/247395401046/u/49/f/654199/c/35217/s/4e68bc3a/sc/19/ach.img (http://adchoice.feedsportal.com/r/247395401046/u/49/f/654199/c/35217/s/4e68bc3a/sc/19/ach.htm)http://pi.feedsportal.com/r/247395401046/u/49/f/654199/c/35217/s/4e68bc3a/sc/19/a2t.imghttp://pi2.feedsportal.com/r/247395401046/u/49/f/654199/c/35217/s/4e68bc3a/sc/19/a2t2.imghttp://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654199/s/4e68bc3a/sc/19/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/businessNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/businessNews?a=YGIf_BXzFBo:bL5otZzJY3o:yIl2AUoC8zA ) http://feeds.feedburner.com/~ff/reuters/businessNews?i=YGIf_BXzFBo:bL5otZzJY3o:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/businessNews?a=YGIf_BXzFBo:bL5otZzJY3o:F7zBnMyn0Lo ) http://feeds.feedburner.com/~ff/reuters/businessNews?i=YGIf_BXzFBo:bL5otZzJY3o:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/businessNews?a=YGIf_BXzFBo:bL5otZzJY3o:V_sGLiPBpWU )
http://feeds.feedburner.com/~r/reuters/businessNews/~4/YGIf_BXzFBo
(Reuters) - Drugmaker Valeant Pharmaceuticals International Inc said on Monday its chief executive ******r is leaving and billionaire investor William Ackman would join the board as it tries to clean up accounting problems and save its business. The Canadian company, whose operations include prescription *****, consumer products, and Bausch & Lomb eye care, has lost nearly 90 percent of its value as it came under public scrutiny for its pricing and distribution pra
http://rc.feedsportal.com/r/247395401046/u/49/f/654199/c/35217/s/4e68bc3a/sc/19/rc/1/rc.img (http://rc.feedsportal.com/r/247395401046/u/49/f/654199/c/35217/s/4e68bc3a/sc/19/rc/1/rc.htm)
http://rc.feedsportal.com/r/247395401046/u/49/f/654199/c/35217/s/4e68bc3a/sc/19/rc/2/rc.img (http://rc.feedsportal.com/r/247395401046/u/49/f/654199/c/35217/s/4e68bc3a/sc/19/rc/2/rc.htm)
http://rc.feedsportal.com/r/247395401046/u/49/f/654199/c/35217/s/4e68bc3a/sc/19/rc/3/rc.img (http://rc.feedsportal.com/r/247395401046/u/49/f/654199/c/35217/s/4e68bc3a/sc/19/rc/3/rc.htm)
http://da.feedsportal.com/r/247395401046/u/49/f/654199/c/35217/s/4e68bc3a/sc/19/a2.img (http://da.feedsportal.com/r/247395401046/u/49/f/654199/c/35217/s/4e68bc3a/sc/19/a2.htm)
http://adchoice.feedsportal.com/r/247395401046/u/49/f/654199/c/35217/s/4e68bc3a/sc/19/ach.img (http://adchoice.feedsportal.com/r/247395401046/u/49/f/654199/c/35217/s/4e68bc3a/sc/19/ach.htm)http://pi.feedsportal.com/r/247395401046/u/49/f/654199/c/35217/s/4e68bc3a/sc/19/a2t.imghttp://pi2.feedsportal.com/r/247395401046/u/49/f/654199/c/35217/s/4e68bc3a/sc/19/a2t2.imghttp://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654199/s/4e68bc3a/sc/19/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/businessNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/businessNews?a=YGIf_BXzFBo:bL5otZzJY3o:yIl2AUoC8zA ) http://feeds.feedburner.com/~ff/reuters/businessNews?i=YGIf_BXzFBo:bL5otZzJY3o:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/businessNews?a=YGIf_BXzFBo:bL5otZzJY3o:F7zBnMyn0Lo ) http://feeds.feedburner.com/~ff/reuters/businessNews?i=YGIf_BXzFBo:bL5otZzJY3o:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/businessNews?a=YGIf_BXzFBo:bL5otZzJY3o:V_sGLiPBpWU )
http://feeds.feedburner.com/~r/reuters/businessNews/~4/YGIf_BXzFBo